190 related articles for article (PubMed ID: 33163776)
21. Chlorinated Withanolides from Withania somnifera.
Tong X; Zhang H; Timmermann BN
Phytochem Lett; 2011 Dec; 4(4):411-414. PubMed ID: 22125584
[TBL] [Abstract][Full Text] [Related]
22. [Overcoming several neurodegenerative diseases by traditional medicines: the development of therapeutic medicines and unraveling pathophysiological mechanisms].
Tohda C
Yakugaku Zasshi; 2008 Aug; 128(8):1159-67. PubMed ID: 18670181
[TBL] [Abstract][Full Text] [Related]
23. Molecular characterization of three CYP450 genes reveals their role in withanolides formation and defense in Withania somnifera, the Indian Ginseng.
Shilpashree HB; Sudharshan SJ; Shasany AK; Nagegowda DA
Sci Rep; 2022 Jan; 12(1):1602. PubMed ID: 35102209
[TBL] [Abstract][Full Text] [Related]
24. An updated review on phytochemistry and molecular targets of
Bashir A; Nabi M; Tabassum N; Afzal S; Ayoub M
Front Pharmacol; 2023; 14():1049334. PubMed ID: 37063285
[No Abstract] [Full Text] [Related]
25. Withania somnifera attenuates acid production, acid tolerance and extra-cellular polysaccharide formation of Streptococcus mutans biofilms.
Pandit S; Song KY; Jeon JG
Am J Chin Med; 2014; 42(1):157-71. PubMed ID: 24467542
[TBL] [Abstract][Full Text] [Related]
26. Enhanced withanolide production by overexpression of squalene synthase in Withania somnifera.
Grover A; Samuel G; Bisaria VS; Sundar D
J Biosci Bioeng; 2013 Jun; 115(6):680-5. PubMed ID: 23313565
[TBL] [Abstract][Full Text] [Related]
27. Direct evidence for GABAergic activity of Withania somnifera on mammalian ionotropic GABAA and GABAρ receptors.
Candelario M; Cuellar E; Reyes-Ruiz JM; Darabedian N; Feimeng Z; Miledi R; Russo-Neustadt A; Limon A
J Ethnopharmacol; 2015 Aug; 171():264-72. PubMed ID: 26068424
[TBL] [Abstract][Full Text] [Related]
28. Withania somnifera and Its Withanolides Attenuate Oxidative and Inflammatory Responses and Up-Regulate Antioxidant Responses in BV-2 Microglial Cells.
Sun GY; Li R; Cui J; Hannink M; Gu Z; Fritsche KL; Lubahn DB; Simonyi A
Neuromolecular Med; 2016 Sep; 18(3):241-52. PubMed ID: 27209361
[TBL] [Abstract][Full Text] [Related]
29. Improving the inhibition of β-amyloid aggregation by withanolide and withanoside derivatives.
Dubey S; Kallubai M; Subramanyam R
Int J Biol Macromol; 2021 Mar; 173():56-65. PubMed ID: 33465364
[TBL] [Abstract][Full Text] [Related]
30. Cytotoxic Withanolides from the Roots of Indian Ginseng ( Withania somnifera).
Kim S; Yu JS; Lee JY; Choi SU; Lee J; Kim KH
J Nat Prod; 2019 Apr; 82(4):765-773. PubMed ID: 30776236
[TBL] [Abstract][Full Text] [Related]
31. In vitro protective effects of Withania somnifera (L.) dunal root extract against hydrogen peroxide and β-amyloid(1-42)-induced cytotoxicity in differentiated PC12 cells.
Kumar S; Seal CJ; Howes MJ; Kite GC; Okello EJ
Phytother Res; 2010 Oct; 24(10):1567-74. PubMed ID: 20680931
[TBL] [Abstract][Full Text] [Related]
32. New withanolides from leaves along with alkyl glucoside from roots and stem as well as variations in withanolide contents in leaves of accessions of
Lal P; Misra L; Sangwan NS; Sangwan RS
J Asian Nat Prod Res; 2024 Feb; ():1-15. PubMed ID: 38311941
[TBL] [Abstract][Full Text] [Related]
33. Withanolide A is inherently de novo biosynthesized in roots of the medicinal plant Ashwagandha (Withania somnifera).
Sangwan RS; Das Chaurasiya N; Lal P; Misra L; Tuli R; Sangwan NS
Physiol Plant; 2008 Jun; 133(2):278-87. PubMed ID: 18312497
[TBL] [Abstract][Full Text] [Related]
34. Antitumor Potential of Withanolide Glycosides from Ashwagandha (
Lee D; Yu JS; Ha JW; Lee SR; Lee BS; Kim JC; Kim JK; Kang KS; Kim KH
Antioxidants (Basel); 2022 Sep; 11(9):. PubMed ID: 36139835
[TBL] [Abstract][Full Text] [Related]
35. RNAi of Sterol Methyl Transferase1 Reveals its Direct Role in Diverting Intermediates Towards Withanolide/Phytosterol Biosynthesis in Withania somnifera.
Pal S; Rastogi S; Nagegowda DA; Gupta MM; Shasany AK; Chanotiya CS
Plant Cell Physiol; 2019 Mar; 60(3):672-686. PubMed ID: 30541044
[TBL] [Abstract][Full Text] [Related]
36. Accumulation of three important bioactive compounds in different plant parts of Withania somnifera and its determination by the LC-ESI-MS-MS (MRM) method.
Gajbhiye NA; Makasana J; Kumar S
J Chromatogr Sci; 2015; 53(10):1749-56. PubMed ID: 26153381
[TBL] [Abstract][Full Text] [Related]
37. Growth inhibition of human tumor cell lines by withanolides from Withania somnifera leaves.
Jayaprakasam B; Zhang Y; Seeram NP; Nair MG
Life Sci; 2003 Nov; 74(1):125-32. PubMed ID: 14575818
[TBL] [Abstract][Full Text] [Related]
38. Recent Advancements in Extraction Techniques of Ashwagandha (
Shinde S; Balasubramaniam AK; Mulay V; Saste G; Girme A; Hingorani L
ACS Omega; 2023 Nov; 8(44):40982-41003. PubMed ID: 37970011
[TBL] [Abstract][Full Text] [Related]
39. Ashwagandha in brain disorders: A review of recent developments.
Zahiruddin S; Basist P; Parveen A; Parveen R; Khan W; Gaurav ; Ahmad S
J Ethnopharmacol; 2020 Jul; 257():112876. PubMed ID: 32305638
[TBL] [Abstract][Full Text] [Related]
40. Enhanced biosynthesis of withanolides by elicitation and precursor feeding in cell suspension culture of Withania somnifera (L.) Dunal in shake-flask culture and bioreactor.
Sivanandhan G; Selvaraj N; Ganapathi A; Manickavasagam M
PLoS One; 2014; 9(8):e104005. PubMed ID: 25089711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
